ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 733795 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 733795; 2) Community: the network communities that were significantly associated with the response to NSC 733795; 3) Molecule: the relationships between components within communities and NSC 733795; 4) MDR: the compounds that were significantly associated with the NSC 733795.

NSC Compound Enrichment Correlation
NSC 163062 TRIPTOLIDE 0.0139289274573436 0.19738953
NSC 17551 1,3-Propanedione, 1-(3-pyridinyl)-3-(2,4,6-trimethyl- phenyl)- 0.0139289274573436 0.35239299
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.0139289274573436 0.18880702
NSC 208734 ACLACINOMYCIN A 0.0139289274573436 0.23261591
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0139289274573436 0.27464893
NSC 23936 Null 0.0139289274573436 0.38128177
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0139289274573436 0.19269625
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0139289274573436 0.19954546
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0139289274573436 0.3273755
NSC 403572 Acetophenone, 4'-bromo-2-hydroxy-, benzoate (8CI) 0.0139289274573436 0.15788388
Total:129  Current:53    [First] [Prev] [Next] [Last]